11/14/2024
3:53 PM | Aprea Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/07/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:38 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
4:42 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
7:30 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
8:00 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:30 AM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/16/2024
7:30 AM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:30 AM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:31 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:30 AM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:31 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:31 AM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:15 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:16 PM | Aprea Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:17 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:18 PM | Aprea Therapeutics (Issuer)
Peters Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:19 PM | Aprea Therapeutics (Issuer)
Pamukcu Rifat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
3:15 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2024
3:16 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
6:34 AM | Aprea Therapeutics (Filer)
| Form 424B3 | |
04/29/2024
11:15 PM | Aprea Therapeutics (Filer)
| Form EFFECT | |
04/25/2024
6:30 AM | Aprea Therapeutics (Filer)
| Form ARS | |
04/25/2024
6:15 AM | Aprea Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
6:00 AM | Aprea Therapeutics (Filer)
| Form DEF 14A | |
04/10/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:59 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
4:57 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:15 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
6:45 AM | Aprea Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
7:51 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:52 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:53 PM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:54 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A huge crack is forming in the US economy (Ad) Former Trump Advisor Warning: “An Economic Rupture Is Coming”
The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.” Learn how to protect yourself too, click here. |
03/12/2024
3:31 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:00 AM | Aprea Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:55 PM | Aprea Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/06/2024
4:01 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2024
11:15 PM | Aprea Therapeutics (Filer)
| Form EFFECT | |
01/26/2024
6:13 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
5:03 AM | Aprea Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
3:16 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free APRE Stock Alerts